Abstract：Objective To investigate the effect of Prostaglandin(PGE1)on pulmonary arterial pressure and pulmonary function in patients with chronic obstructive pulmonary disease(COPD)complicated with chronic cor pulmonale.Methods From May 2016 to October 2017,62 patients with COPD complicated with chronic cor pulmonale in our hospital were randomly divided into two groups,31cases in each group.The control group was received routine treatment and the study group was treated with Alprostadil.The clinical effect of two groups was observed and analyzed.Results Before treatment,FEV1/FVC and FEV1of two groups were no significant differences between forced expiratory volume of one second,forced vital capacity,forced expiratory volume of one second and pulmonary arterial pressure(P＞0.05).After treatment,FEV1/FVC and FEV1were all expected higher in the study group,the pulmonary arterial pressure was lower than that in the control group(P＜0.05).There was no significant difference in pulmonary capillary permeability between the two groups before treatment(P＞0.05),and after treatment,pulmonary capillary permeability was better in the study group than in the control group(P＜0.05).Before treatment,there was no significant difference between the two groups in the partial pressure of oxygen(PaO2)and the oxygenation index[P(A-A)O2](P＞0.05).After treatment,PaO2was higher in the study group than that in the control group,P(A-a)O2was lower than that in the control group,the differences were statistically significant （P＜0.05）.Conclusion The application of Alprostadil in COPD patients with chronic pulmonary heart disease can achieve the exact effect and improve the pulmonary function.
易小莉;李仕雄;甄新现. 前列地尔在慢性阻塞性肺疾病合并慢性肺心病患者治疗中的应用效果[J]. 中国当代医药, 2018, 25(9): 53-55.
YI Xiao-li;LI Shi-xiong;ZHEN New-xian. Application effect of Alprostadil in the treatment of patients with chronic obstructive pulmonary disease and chronic cor pulmonale. 中国当代医药, 2018, 25(9): 53-55.
京公网安备 11010502046607号